These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9338537)
1. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537 [TBL] [Abstract][Full Text] [Related]
2. [Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]. Tworek D; Bocheńska-Marciniak M; Kupczyk M; Kupryś-Lipińska I; Kuna P Pneumonol Alergol Pol; 2006; 74(2):153-8. PubMed ID: 17269362 [TBL] [Abstract][Full Text] [Related]
3. New developments in the diagnosis and treatment of hymenoptera venom allergy. Müller UR Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327 [TBL] [Abstract][Full Text] [Related]
4. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy. Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155 [TBL] [Abstract][Full Text] [Related]
5. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Berchtold E; Maibach R; Müller U Clin Exp Allergy; 1992 Jan; 22(1):59-65. PubMed ID: 1551035 [TBL] [Abstract][Full Text] [Related]
6. Peanut Oral Immunotherapy With or Without H Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280 [TBL] [Abstract][Full Text] [Related]
7. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain. Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943 [TBL] [Abstract][Full Text] [Related]
8. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Reimers A; Hari Y; Müller U Allergy; 2000 May; 55(5):484-8. PubMed ID: 10843430 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. Paul E; Bödeker RH Eur J Clin Pharmacol; 1986; 31(3):277-80. PubMed ID: 2878811 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects. Kanbak M; Kahraman S; Celebioglu B; Akpolat N; Ercan S; Erdem K Anaesth Intensive Care; 1996 Oct; 24(5):559-63. PubMed ID: 8909666 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies]. Paul E; Pfeffer M; Bödeker RH Z Hautkr; 1987 Mar; 62(5):401-2, 405-6. PubMed ID: 2884788 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan. Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126 [TBL] [Abstract][Full Text] [Related]
14. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Sharpe GR; Shuster S Br J Dermatol; 1993 Nov; 129(5):575-9. PubMed ID: 8251354 [TBL] [Abstract][Full Text] [Related]
15. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis. Holmberg K; Pipkorn U; Bake B; Blychert LO Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579 [TBL] [Abstract][Full Text] [Related]
17. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200 [TBL] [Abstract][Full Text] [Related]